Managing Director of New Ventures

ABOUT THE COMPANY: Redesign Health https://www.redesignhealth.com/ is a global venture and applied technology firm focused on building next-generation healthcare companies. We manage venture capital and venture buyout strategies, each powered by an AI operating system and team of leading technologists, entrepreneurs, and investors. Our venture capital strategy backs exceptional founders at the earliest stage—often before an idea is fully formed—and provides first institutional capital and an unmatched degree of strategic leverage and domain expertise through exit. Our venture buyout strategy partners with proven management teams through control investments and delivers outsized value by rewiring core products and workflows with AI. Since inception in 2018, Redesign and our portfolio companies have touched the lives of more than 15 million patients, raised over $1.5 billion from premier institutional, sovereign, and strategic investors, and built distinctive partnerships with marquee healthcare organizations and senior leaders around the world. Redesign is based in New York and has offices in Bengaluru, Los Angeles, and Riyadh. About the Role: As a Managing Director of New Ventures, you will back exceptional founders at the earliest stage—often before an idea is fully formed—providing first institutional capital and an unmatched degree of strategic leverage and domain expertise through launch and beyond. This role demands generative ideation, exceptional founder judgment, and the ability to sell world-class entrepreneurs on partnering with Redesign Health. You will develop original investment theses in healthcare, identify and attract top 1% founding talent, lead co-ideation and diligence through Investment Committee, and serve as the primary interface between portfolio founders and Redesign’s platform. The core equation: Exceptional Founders × Differentiated Concepts × Redesign’s X-Factors = Power-Law Outcomes. WHAT YOU’LL DO: THESIS & IDEATION: Identify white space in healthcare where AI-native businesses can create outsized outcomes. Develop original, high-conviction investment theses grounded in deep market understanding, clinician pain points, and structural tailwinds. Generate concepts that are bold, differentiated, and commercially viable. Validate theses through primary conversations with clinicians, operators, payers, and potential customers—not just desktop research. Draft compelling collateral that attracts world-class founders to Redesign’s platform. FOUNDER SOURCING, SELLING & CO-IDEATION: Find top 1% founders and convince them that Redesign is their best path to building a generational healthcare company. Build a network that surfaces exceptional talent before anyone else sees them. Demonstrate Redesign’s strategic leverage compellingly enough that founders choose us. Lead a collaborative diligence process (“co-ideation”) to transform thematic areas into venture-scale business concepts. Evaluate concept potential and founder-market fit with the judgment to say no quickly when conviction is lacking—time spent on mediocre opportunities is time away from exceptional ones. DILIGENCE & IC DELIVERY: Stress-test your own theses harder than anyone else will. Identify the 2–3 questions that truly matter for each investment and resolve them through primary conversations and expert input. Shepherd founders and concepts to the Investment Committee with clarity, speed, and honest representation of risks. NETWORK & ECOSYSTEM BUILDING: Develop a robust pipeline of exceptional founders through proactive sourcing across VC networks, healthcare operator communities, and the broader startup ecosystem. Build and maintain deep relationships with tier-one venture capital firms, healthcare incumbents, and strategic investors. Be the person that founders proactively seek out, VCs call for pipeline intelligence, and the industry turns to for a healthcare venture perspective. Your network is a compounding asset—invest in it every week. POR